{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:43:46Z","timestamp":1783035826192,"version":"3.54.6"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031403","name":"University of Kragujevac","doi-asserted-by":"publisher","award":["JP10-24"],"award-info":[{"award-number":["JP10-24"]}],"id":[{"id":"10.13039\/100031403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010301","name":"University of Kragujevac Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-65\/2024-03\/200111"],"award-info":[{"award-number":["451-03-65\/2024-03\/200111"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-66\/2024-03\/200111"],"award-info":[{"award-number":["451-03-66\/2024-03\/200111"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopha.2025.117931","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T03:07:34Z","timestamp":1739934454000},"page":"117931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Unlocking the molecular mechanisms of anticancer and immunomodulatory potentials of cariprazine in triple negative breast cancer"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8273-3379","authenticated-orcid":false,"given":"Aleksandar","family":"Lazovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana Simovic","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Corovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7726-1716","authenticated-orcid":false,"given":"Tijana","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Andjelkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojan","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7970-0293","authenticated-orcid":false,"given":"Marina","family":"Mitrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"56A","key":"10.1016\/j.biopha.2025.117931_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.9734\/jpri\/2021\/v33i56A33889","article-title":"Therapeutic targets in breast cancer signaling: a review","volume":"33","author":"Obeagu","year":"2021","journal-title":"J. Pharm. Res. Int."},{"issue":"31","key":"10.1016\/j.biopha.2025.117931_bib2","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1200\/JCO.2013.50.9984","article-title":"Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline update","volume":"31","author":"Wolff","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"15 Pt 1","key":"10.1016\/j.biopha.2025.117931_bib3","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin. Cancer Res"},{"issue":"9","key":"10.1016\/j.biopha.2025.117931_bib4","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2025.117931_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.biopha.2025.117931_bib6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.bjc.6603259","article-title":"Cancer risk among users of neuroleptic medication: a population-based cohort study","volume":"95","author":"Dalton","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.117931_bib7","unstructured":"M.M. Borovcanin, B. Stojanovic, M. Dimitrijevic Stojanovic, B.S. Stojanovic, A. Lazovic, M. Mitrovic, Anticancer Properties of Antipsychotic Drugs, Springer International Publishing, Cham, pp. 1-26."},{"issue":"1","key":"10.1016\/j.biopha.2025.117931_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mehy.2012.03.026","article-title":"Antipsychotic drugs: pro-cancer or anti-cancer? A systematic review","volume":"79","author":"Fond","year":"2012","journal-title":"Med. Hypotheses"},{"issue":"12","key":"10.1016\/j.biopha.2025.117931_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9121785","article-title":"Repurposing antipsychotics for cancer treatment","volume":"9","author":"Vlachos","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.117931_bib10","article-title":"Penfluridol regulates p62 \/ Keap1 \/ Nrf2 signaling pathway to induce ferroptosis in osteosarcoma cells","volume":"177","author":"Zeng","year":"2024","journal-title":"Biomed. Pharmacother. =\u2009Biomedecine Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2025.117931_bib11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/1871527321666220324121935","article-title":"Mini review on cariprazine: a promising antipsychotic agent","volume":"22","author":"Patel","year":"2023","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"9","key":"10.1016\/j.biopha.2025.117931_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090308","article-title":"Cariprazine, A dopamine D\u2082\/D\u2083 receptor partial agonist, modulates ABCG2-mediated multidrug resistance in cancer","volume":"10","author":"Hussein","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.biopha.2025.117931_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1515725","article-title":"Olanzapine for the prevention of chemotherapy-induced nausea and vomiting","volume":"375","author":"Navari","year":"2016","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.biopha.2025.117931_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070304","article-title":"Multicentre, randomised, double-blind, placebo-controlled phase II study of prophylactic olanzapine for patients with metastatic breast cancer receiving T-DXd treatment: protocol for the ERICA study (WJOG14320B)","volume":"13","author":"Sakai","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.biopha.2025.117931_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-014-1688-7","article-title":"Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect","volume":"122","author":"Karpel-Massler","year":"2015","journal-title":"J. Neurooncol"},{"issue":"11","key":"10.1016\/j.biopha.2025.117931_bib16","first-page":"6177","article-title":"T. Sanomachi, S. Suzuki, K. Kuramoto, H. Takeda, H. Sakaki, K. Togashi, S. Seino, T. Yoshioka, M. Okada, C. Kitanaka, Olanzapine, an Atypical Antipsychotic, Inhibits Survivin Expression and Sensitizes Cancer Cells to Chemotherapeutic Agents","volume":"37","year":"2017","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.117931_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/ijnpnd.IJNPND_82_21","article-title":"Antiproliferative effects of olanzapine against MCF-7 Cells and Its Molecular Interactions with Survivin","volume":"12","author":"Vedam","year":"2022","journal-title":"Int. J. Nutr., Pharmacol., Neurol. Dis."},{"issue":"8","key":"10.1016\/j.biopha.2025.117931_bib18","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/npp.2014.38","article-title":"Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a \u03b2arrestin2-independent activation of Akt","volume":"39","author":"Schmid","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.biopha.2025.117931_bib19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1159\/000369751","article-title":"Clozapine induces autophagic cell death in non-small cell lung cancer cells","volume":"35","author":"Yin","year":"2015","journal-title":"Cell Physiol. Biochem"},{"issue":"11","key":"10.1016\/j.biopha.2025.117931_bib20","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.cellsig.2006.02.004","article-title":"Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+\u2009\/calmodulin in PTEN-negative U-87MG human glioblastoma cells","volume":"18","author":"Shin","year":"2006","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.biopha.2025.117931_bib21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jdermsci.2013.07.012","article-title":"Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma","volume":"72","author":"Massari","year":"2013","journal-title":"J. Dermatol. Sci."},{"issue":"ement_2","key":"10.1016\/j.biopha.2025.117931_bib22","article-title":"P10.13.B Repurposing neuroleptics to treat brain metastases: Clozapine as a novel therapy for melanoma brain metastases","volume":"24","author":"Wikerholmen","year":"2022","journal-title":"Neuro-Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2025.117931_bib23","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1007\/s11033-021-06752-9","article-title":"Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets","volume":"48","author":"Kumar","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2025.117931_bib24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.4049\/jimmunol.2000646","article-title":"Characterization of clozapine-responsive human T cells","volume":"205","author":"Ogese","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2025.117931_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.12659\/MSMBR.893327","article-title":"Dual AO\/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry","volume":"21","author":"Liu","year":"2015","journal-title":"Med Sci. Monit. Basic Res"},{"issue":"2","key":"10.1016\/j.biopha.2025.117931_bib26","first-page":"439","article-title":"A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles","volume":"61","author":"Paglin","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.117931_bib27","article-title":"A simple method for quantitating confocal fluorescent images","volume":"25","author":"Shihan","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.biopha.2025.117931_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2022.111773","article-title":"Platinum(II) complexes with malonic acids: Synthesis, characterization, in vitro and in vivo antitumor activity and interactions with biomolecules","volume":"231","author":"Dimitrijevi\u0107 Stojanovi\u0107","year":"2022","journal-title":"J. Inorg. Biochem"},{"issue":"7","key":"10.1016\/j.biopha.2025.117931_bib29","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1002\/eji.201141417","article-title":"ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma","volume":"41","author":"Jovanovic","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2025.117931_bib30","doi-asserted-by":"crossref","first-page":"0","DOI":"10.5937\/KgJSci2400003S","article-title":"Immunomodulatory effects of mononuclear 5,6- epoxy-5,6-dihydro-1,10-phenanthroline platinum(II) complex","volume":"46","author":"Stanisavljevic","year":"2024","journal-title":"Kragujev. J. Sci."},{"key":"10.1016\/j.biopha.2025.117931_bib31","first-page":"1315378","article-title":"Mesenchymal stem cells attenuate cisplatin-induced nephrotoxicity in inos-dependent manner","author":"Markovic","year":"2017","journal-title":"Stem Cells Int 2017"},{"key":"10.1016\/j.biopha.2025.117931_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.562196","article-title":"Psychotropic drugs show anticancer activity by disrupting mitochondrial and lysosomal function","volume":"10","author":"Varalda","year":"2020","journal-title":"Front Oncol."},{"issue":"11","key":"10.1016\/j.biopha.2025.117931_bib33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.15698\/cst2018.11.161","article-title":"Mechanisms and therapeutic significance of autophagy modulation by antipsychotic drugs","volume":"2","author":"Vucicevic","year":"2018","journal-title":"Cell Stress"},{"issue":"1","key":"10.1016\/j.biopha.2025.117931_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7150\/ijbs.65763","article-title":"Common genomic aberrations in mouse and human breast cancers with concurrent P53 deficiency and activated PTEN-PI3K-AKT pathway","volume":"18","author":"Martinez","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.117931_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17062078","article-title":"Triple-negative breast cancer: a review of conventional and advanced therapeutic strategies","volume":"17","author":"Medina","year":"2020","journal-title":"Int J. Environ. Res Public Health"},{"key":"10.1016\/j.biopha.2025.117931_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS2073","article-title":"Phase II multicentric Italian trial on repositioning of the antipsychotic drug chlorpromazine and its combination with temozolomide in patients with MGMT unmethylated glioblastoma: The RACTAC trial","volume":"40","author":"Lombardi","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117931_bib37","doi-asserted-by":"crossref","DOI":"10.1177\/2045125320905752","article-title":"Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data","volume":"10","author":"Stahl","year":"2020","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117931_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1124\/jpet.119.256818","article-title":"Cancer and the dopamine D(2) receptor: a pharmacological perspective","volume":"370","author":"Weissenrieder","year":"2019","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.117931_bib39","first-page":"243","article-title":"5-HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability","author":"Ballou","year":"2018","journal-title":"Mol. Clin. Oncol. 9(3"},{"key":"10.1016\/j.biopha.2025.117931_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.05.031","article-title":"Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment","volume":"856","author":"Hendouei","year":"2019","journal-title":"Eur. J. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2025.117931_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25126546","article-title":"Expression profiles of dopamine-related genes and mirnas regulating their expression in breast cancer","volume":"25","author":"Sirek","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.biopha.2025.117931_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26113171","article-title":"The role of serotonin in breast cancer stem cells","volume":"26","author":"Gwynne","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.biopha.2025.117931_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235676","article-title":"Antipsychotics drug aripiprazole as a lead against breast cancer cell line (MCF-7) in vitro","volume":"15","author":"Badran","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117931_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113063","article-title":"Pimozide inhibits the growth of breast cancer cells by alleviating the Warburg effect through the P53 signaling pathway","volume":"150","author":"Li","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"10","key":"10.1016\/j.biopha.2025.117931_bib45","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41419-018-1046-3","article-title":"The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0\/G1 arrest and apoptosis","volume":"9","author":"Feng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"79","key":"10.1016\/j.biopha.2025.117931_bib46","doi-asserted-by":"crossref","first-page":"34889","DOI":"10.18632\/oncotarget.26175","article-title":"The anti-psychotic drug pimozide is a novel chemotherapeutic for breast cancer","volume":"9","author":"Dakir el","year":"2018","journal-title":"Oncotarget"},{"issue":"24","key":"10.1016\/j.biopha.2025.117931_bib47","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1080\/15384101.2020.1850969","article-title":"Thioridazine hydrochloride: an antipsychotic agent that inhibits tumor growth and lung metastasis in triple-negative breast cancer via inducing G0\/G1 arrest and apoptosis","volume":"19","author":"Song","year":"2020","journal-title":"Cell Cycle"},{"issue":"7","key":"10.1016\/j.biopha.2025.117931_bib48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.117931_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115665","article-title":"Pimavanserin tartrate induces apoptosis and cytoprotective autophagy and synergizes with chemotherapy on triple negative breast cancer","volume":"168","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2025.117931_bib50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.15171\/apb.2019.024","article-title":"Understanding apoptosis and apoptotic pathways targeted cancer therapeutics","volume":"9","author":"Jan","year":"2019","journal-title":"Adv. Pharm. Bull."},{"issue":"24","key":"10.1016\/j.biopha.2025.117931_bib51","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.3390\/cancers14246047","article-title":"An evaluation of the anticancer properties of SYA014, a homopiperazine-oxime analog of haloperidol in triple negative breast cancer cells","volume":"14","author":"Asong","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.biopha.2025.117931_bib52","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in Context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biopha.2025.117931_bib53","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41568-020-0262-1","article-title":"A.J. Levine, p53: 800 million years of evolution and 40 years of discovery","volume":"20","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.117931_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.761080","article-title":"p53 modulation of autophagy signaling in cancer therapies: perspectives mechanism and therapeutic targets","volume":"10","author":"Rahman","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.117931_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030564","article-title":"Mechanisms of cell cycle arrest and apoptosis in glioblastoma","volume":"10","author":"Gousias","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.biopha.2025.117931_bib56","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1158\/0008-5472.CAN-16-2098","article-title":"The p53\/p21 complex regulates cancer cell invasion and apoptosis by targeting Bcl-2 family proteins","volume":"77","author":"Kim","year":"2017","journal-title":"Cancer Res"},{"issue":"29","key":"10.1016\/j.biopha.2025.117931_bib57","doi-asserted-by":"crossref","first-page":"27580","DOI":"10.18632\/oncotarget.4768","article-title":"Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.117931_bib58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fonc.2015.00288","article-title":"Targeting oncogenic mutant p53 for cancer therapy","volume":"5","author":"Parrales","year":"2015","journal-title":"Front Oncol."},{"key":"10.1016\/j.biopha.2025.117931_bib59","first-page":"1213","article-title":"Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma","author":"Liao","year":"2019","journal-title":"Int J. Oncol. 55(6"},{"issue":"8","key":"10.1016\/j.biopha.2025.117931_bib60","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tem.2023.05.004","article-title":"The emerging potential role of p62 in cancer treatment by regulating metabolism","volume":"34","author":"Zhang","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.biopha.2025.117931_bib61","doi-asserted-by":"crossref","DOI":"10.1515\/ntrev-2023-0148","article-title":"Induction of apoptosis and autophagy via regulation of AKT and JNK mitogen-activated protein kinase pathways in breast cancer cell lines exposed to gold nanoparticles loaded with TNF-\u03b1 and combined with doxorubicin","volume":"12","author":"Jawad","year":"2023","journal-title":"Nanotechnol. Rev."},{"issue":"9","key":"10.1016\/j.biopha.2025.117931_bib62","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1093\/carcin\/bgt169","article-title":"The antipsychotic agent chlorpromazine induces autophagic cell death by inhibiting the Akt\/mTOR pathway in human U-87MG glioma cells","volume":"34","author":"Shin","year":"2013","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.biopha.2025.117931_bib63","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41419-024-06779-3","article-title":"Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN","volume":"15","author":"Jacob","year":"2024","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.biopha.2025.117931_bib64","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41556-022-00949-1","article-title":"A p53-phosphoinositide signalosome regulates nuclear AKT activation","volume":"24","author":"Chen","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117931_bib65","doi-asserted-by":"crossref","first-page":"1320621","DOI":"10.3389\/fonc.2023.1320621","article-title":"Repurposing phenothiazines for cancer therapy: compromising membrane integrity in cancer cells","volume":"13","author":"Mehrabi","year":"2023","journal-title":"Front Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2025.117931_bib66","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1158\/0008-5472.CAN-15-1233","article-title":"Penfluridol: an antipsychotic agent suppresses metastatic tumor growth in triple-negative breast cancer by inhibiting integrin signaling axis","volume":"76","author":"Ranjan","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.117931_bib67","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3389\/fphar.2019.01262","article-title":"Surprising anticancer activities of psychiatric medications: old drugs offer new hope for patients with brain cancer","volume":"10","author":"Zhuo","year":"2019","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2025.117931_bib68","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/104012371803000410","article-title":"Use of cariprazine in psychiatric disorders: a systematic review","volume":"30","author":"Chhatlani","year":"2018","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2025.117931_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/bdi.13421","article-title":"Cariprazine as a maintenance therapy in the prevention of mood episodes in adults with bipolar I disorder","author":"McIntyre","year":"2024","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.biopha.2025.117931_bib70","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2147\/NDT.S301225","article-title":"Safety and tolerability of cariprazine in patients with schizophrenia: a pooled analysis of eight phase II\/III studies","volume":"17","author":"Barab\u00e1ssy","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"11","key":"10.1016\/j.biopha.2025.117931_bib71","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2174\/092986706776872970","article-title":"Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin","volume":"13","author":"Abu-Surrah","year":"2006","journal-title":"Curr. Med Chem."},{"issue":"15","key":"10.1016\/j.biopha.2025.117931_bib72","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.117931_bib73","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1038\/srep03456","article-title":"IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1\/2","volume":"3","author":"Cochaud","year":"2013","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2025.117931_bib74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12013-011-9276-3","article-title":"Expression of Th17 cells in breast cancer tissue and its association with clinical parameters","volume":"62","author":"Yang","year":"2012","journal-title":"Cell Biochem Biophys."},{"issue":"12","key":"10.1016\/j.biopha.2025.117931_bib75","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.188.12.2199","article-title":"The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses","volume":"188","author":"Kalams","year":"1998","journal-title":"J. Exp. Med"},{"issue":"3","key":"10.1016\/j.biopha.2025.117931_bib76","first-page":"827","article-title":"Pillars Article: IFN\u03b3 and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity","volume":"201","author":"Shankaran","year":"2018","journal-title":"Nat. 2001. 410: 1107-1111, J. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2025.117931_bib77","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s10585-013-9602-9","article-title":"Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+\u2009Tregs","volume":"30","author":"Demir","year":"2013","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"1","key":"10.1016\/j.biopha.2025.117931_bib78","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12885-016-2732-0","article-title":"Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+\u2009Tregs: a systematic review and meta-analysis","volume":"16","author":"Shou","year":"2016","journal-title":"BMC Cancer"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:38:34Z","timestamp":1778693914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":78,"alternative-id":["S0753332225001258"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117931","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the molecular mechanisms of anticancer and immunomodulatory potentials of cariprazine in triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117931"}}